-
1دورية أكاديمية
المؤلفون: Neyt, Mattias Mattias.neyt@kce.fgov.be, Cleemput, Irina1, Thiry, Nancy1, De Laet, Chris1
المصدر: Health Policy. Jul2012, Vol. 106 Issue 2, p207-210. 4p.
مصطلحات موضوعية: *COST effectiveness, *DATA analysis, *MEDICAL economics, *PARAMETER estimation, *PERFORMANCE evaluation, RANDOMIZED controlled trials
-
2دورية أكاديمية
المؤلفون: Neyt, Mattias
المساهمون: Devos, Carl, Thiry, Nancy, De Gendt, Cindy, Van Damme, Nancy, Castanares-Zapatero, Diego, Fairon, Nicolas, Hulstaert, Frank, Verleye, Leen, Silversmit, Geert
مصطلحات موضوعية: Antineoplastic Agents, Neoplasms, QV 269 Antineoplastic agents. Antineoplastic antibiotics, R343, Randomized Controlled Trials, Review, Technology Assessment, Biomedical
الوقت: 2018-02
وصف الملف: A4
العلاقة: KCE Reports; Health Technology Assessment (HTA); Vignette : https://kce.docressources.info/thumbnail.php?type=1&id=4749Test; https://kce.docressources.info/index.php?lvl=notice_display&id=4749Test; 4749; urn:ISBN:D/2021/10.273/24
-
3دورية أكاديمية
المؤلفون: Neyt, Mattias
المساهمون: Devos, Carl, Thiry, Nancy, De Gendt, Cindy, Van Damme, Nancy, Castanares-Zapatero, Diego, Fairon, Nicolas, Hulstaert, Frank, Verleye, Leen, Silversmit, Geert
مصطلحات موضوعية: Antineoplastic Agents, Neoplasms, QV 269 Antineoplastic agents. Antineoplastic antibiotics, R343, Randomized Controlled Trials, Review, Technology Assessment, Biomedical
الوقت: 2018-02
وصف الملف: A4
العلاقة: KCE Reports; Health Technology Assessment (HTA); Vignette : https://kce.docressources.info/thumbnail.php?type=1&id=4747Test; https://kce.docressources.info/index.php?lvl=notice_display&id=4747Test; 4747; urn:ISBN:D/2021/10.273/23
-
4دورية أكاديمية
المؤلفون: Neyt, Mattias
المساهمون: Devos, Carl, Thiry, Nancy, De Gendt, Cindy, Van Damme, Nancy, Castanares-Zapatero, Diego, Fairon, Nicolas, Hulstaert, Frank, Verleye, Leen, Silversmit, Geert
مصطلحات موضوعية: Antineoplastic Agents, Neoplasms, QV 269 Antineoplastic agents. Antineoplastic antibiotics, R343, Randomized Controlled Trials, Review, Technology Assessment, Biomedical
الوقت: 2018-02
وصف الملف: A4
العلاقة: KCE Reports; Health Technology Assessment (HTA); Vignette : https://kce.docressources.info/thumbnail.php?type=1&id=4748Test; https://kce.docressources.info/index.php?lvl=notice_display&id=4748Test; 4748; urn:ISBN:D/2021/10.273/22
-
5دورية أكاديمية
المؤلفون: Neyt, Mattias
المساهمون: Devos, Carl, Thiry, Nancy, De Gendt, Cindy, Van Damme, Nancy, Castanares-Zapatero, Diego, Fairon, Nicolas, Hulstaert, Frank, Verleye, Leen, Silversmit, Geert
مصطلحات موضوعية: Antineoplastic Agents, Neoplasms, QV 269 Antineoplastic agents. Antineoplastic antibiotics, R343, Randomized Controlled Trials, Review, Technology Assessment, Biomedical
الوقت: 2018-02
وصف الملف: A4
العلاقة: KCE Reports A; Health Technology Assessment (HTA); Vignette : https://kce.docressources.info/thumbnail.php?type=1&id=4750Test; https://kce.docressources.info/index.php?lvl=notice_display&id=4750Test; 4750; urn:ISBN:D/2021/10.273/20
-
6دورية أكاديميةLes médicaments innovants contre le cancer ont-ils toujours une réelle valeur ajoutée ? : – Synthèse
المؤلفون: Neyt, Mattias
المساهمون: Devos, Carl, Thiry, Nancy, De Gendt, Cindy, Van Damme, Nancy, Castanares-Zapatero, Diego, Fairon, Nicolas, Hulstaert, Frank, Verleye, Leen, Silversmit, Geert
مصطلحات موضوعية: Antineoplastic Agents, Neoplasms, QV 269 Antineoplastic agents. Antineoplastic antibiotics, R343, Randomized Controlled Trials, Review, Technology Assessment, Biomedical
الوقت: 2018-02
وصف الملف: A4
العلاقة: KCE Reports B; Health Technology Assessment (HTA); Vignette : https://kce.docressources.info/thumbnail.php?type=1&id=4751Test; https://kce.docressources.info/index.php?lvl=notice_display&id=4751Test; 4751
